Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

adult acute promyelocytic leukemia (M3)

Known as: acute progranulocytic leukemia, adult, progranulocytic leukemia, adult acute, M3 leukemia, adult acute 
An acute promyelocytic leukemia with t(15;17)(q22;q12) occurring in adults.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract In order to explore the prognostic value of CD2, CD4, and human leucocyte antigen-DR (HLA-DR) expression and Fms-like… Expand
2019
2019
PURPOSE To perform a retrospective analysis of the prognostic relevance of clinicopathologic parameters in a well-documented… Expand
Review
2018
Review
2018
ABSTRACT Background and aims: To explore the relationship between FLT3 (encoding Fms related tyrosine kinase 3) internal tandem… Expand
2018
2018
The arsenic trioxide (ATO) plus all‐trans retinoic acid (ATRA) therapy has demonstrated a tremendous success in the first‐line… Expand
2018
2018
2014
2014
Lymphoid enhancer-binding factor 1 (LEF1) is a downstream effector of the Wnt/ β-catenin signaling pathway. High LEF1 expression… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
2011
Review
2011
Treatment-related mortality (TRM) is important in acute lymphoblastic leukemia and acute myeloid leukemia (AML); however, little… Expand
  • table I
2010
2010
OBJECTIVE To investigate the efficacy and treatment outcome of different induction regimens, and different post-remission… Expand
2008
2008
Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of… Expand
  • figure 1
  • figure 2
  • figure 1
Highly Cited
2006
Highly Cited
2006
BACKGROUND AND OBJECTIVES Acute promyelocytic leukemia (APL) is characterized by leukemic cells blocked at the promyelocytic… Expand